$PZG
Paramount Gold Nevada Corp

2020 Q3 Form 10-K Financial Statement

#000156459020044687 Filed on September 25, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2020 Q2 2020
Revenue $68.95K $0.00 $728.9K
YoY Change 119.87% -100.0% 82.05%
Cost Of Revenue $131.2K $191.6K $593.0K
YoY Change -4.65% 12.36% -2.79%
Gross Profit -$62.23K -$191.6K $135.9K
YoY Change -41.41% 14.96% -164.84%
Gross Profit Margin -90.25% 18.65%
Selling, General & Admin $495.2K $396.3K $1.728M
YoY Change 43.74% -18.83% -6.46%
% of Gross Profit 1271.39%
Research & Development $636.0K $865.9K $4.201M
YoY Change 38.7% -43.73% 18.05%
% of Gross Profit 3090.66%
Depreciation & Amortization $630.00 $460.00 $2.555K
YoY Change 36.96% -29.23% -2.48%
% of Gross Profit 1.88%
Operating Expenses $1.147M $1.286M $6.026M
YoY Change 32.98% -38.84% 5.63%
Operating Profit -$1.209M -$1.478M -$5.891M
YoY Change 21.85% -35.81% -0.41%
Interest Expense -$122.5K -$120.7K -$372.7K
YoY Change -877.19% 2363.47% -2205.65%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$1.332M -$1.641M -$6.430M
YoY Change 32.29% -28.89% 7.71%
Income Tax
% Of Pretax Income
Net Earnings -$1.332M -$1.641M -$6.430M
YoY Change 32.29% -28.89% 7.71%
Net Earnings / Revenue -1931.12% -882.16%
Basic Earnings Per Share $0.23
Diluted Earnings Per Share -$39.48K -$58.88K $0.23
COMMON SHARES
Basic Shares Outstanding 33.94M 27.58M
Diluted Shares Outstanding 27.58M

Balance Sheet

Concept 2020 Q3 2020 Q2 2020
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.491M $5.434M $5.434M
YoY Change 7.26% 1071.92% 1071.92%
Cash & Equivalents $4.491M $5.434M $5.434M
Short-Term Investments
Other Short-Term Assets $721.9K $442.6K $442.6K
YoY Change -56.21% 26.9% 26.9%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $5.213M $5.877M $5.877M
YoY Change -10.67% 623.32% 623.32%
LONG-TERM ASSETS
Property, Plant & Equipment $47.34M $47.34M $47.34M
YoY Change 810674.96% 750999.16% 0.6%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $633.1K $695.0K $695.0K
YoY Change -54.22% -50.42% -50.42%
Total Long-Term Assets $47.97M $48.04M $48.04M
YoY Change -0.97% -0.88% -0.88%
TOTAL ASSETS
Total Short-Term Assets $5.213M $5.877M $5.877M
Total Long-Term Assets $47.97M $48.04M $48.04M
Total Assets $53.19M $53.91M $53.91M
YoY Change -2.01% 9.41% 9.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $508.4K $925.3K $925.3K
YoY Change -35.2% -5.62% -5.62%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $599.4K $1.079M $1.079M
YoY Change -32.02% 0.18% 0.18%
LONG-TERM LIABILITIES
Long-Term Debt $5.117M $5.292M $5.292M
YoY Change -1.68%
Other Long-Term Liabilities $476.0K $460.9K $460.9K
YoY Change -45.06% -46.92% -46.92%
Total Long-Term Liabilities $5.593M $5.753M $5.753M
YoY Change -7.87% 562.47% 562.47%
TOTAL LIABILITIES
Total Short-Term Liabilities $599.4K $1.079M $1.079M
Total Long-Term Liabilities $5.593M $5.753M $5.753M
Total Liabilities $6.193M $6.832M $6.832M
YoY Change -10.93% 251.1% 251.1%
SHAREHOLDERS EQUITY
Retained Earnings -$54.13M
YoY Change 13.48%
Common Stock $101.2M
YoY Change 6.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $47.00M $47.08M $47.08M
YoY Change
Total Liabilities & Shareholders Equity $53.19M $53.91M $53.91M
YoY Change -2.01% 9.41% 9.41%

Cashflow Statement

Concept 2020 Q3 2020 Q2 2020
OPERATING ACTIVITIES
Net Income -$1.332M -$1.641M -$6.430M
YoY Change 32.29% -28.89% 7.71%
Depreciation, Depletion And Amortization $630.00 $460.00 $2.555K
YoY Change 36.96% -29.23% -2.48%
Cash From Operating Activities -$1.713M -$898.8K -$5.145M
YoY Change 15.91% -50.78% -8.67%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$4.720K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities $0.00 $0.00 -$4.719K
YoY Change -100.0% -100.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $770.5K $4.883M
YoY Change 67.73%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 770.5K 4.919M 10.12M
YoY Change -85.19% 161.36%
NET CHANGE
Cash From Operating Activities -1.713M -898.8K -5.145M
Cash From Investing Activities 0.000 0.000 -4.719K
Cash From Financing Activities 770.5K 4.919M 10.12M
Net Change In Cash -942.6K 4.020M 4.970M
YoY Change -125.31% 3852.19% 2888.79%
FREE CASH FLOW
Cash From Operating Activities -$1.713M -$898.8K -$5.145M
Capital Expenditures $0.00 -$4.720K
Free Cash Flow -$898.8K -$5.141M
YoY Change -50.78% -8.75%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020 dei Entity Address Address Line1
EntityAddressAddressLine1
665 Anderson Street
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5434081
CY2020Q2 pzg Prepaid And Deposit Assets Current
PrepaidAndDepositAssetsCurrent
442596
CY2020Q2 us-gaap Assets Current
AssetsCurrent
5876677
CY2020Q2 us-gaap Mineral Properties Net
MineralPropertiesNet
47333313
CY2020Q2 pzg Reclamation Bond Noncurrent
ReclamationBondNoncurrent
695041
CY2020Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
48036821
CY2020Q2 us-gaap Assets
Assets
53913498
CY2020Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
925260
CY2020Q2 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
154231
CY2019Q2 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
97287
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1079491
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1077597
CY2020Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
5256228
CY2020Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
35628
CY2020 dei Entity File Number
EntityFileNumber
001-36908
CY2020 dei Security12b Title
Security12bTitle
Common Stock
CY2020 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2020 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2020 dei Entity Shell Company
EntityShellCompany
false
CY2020 dei Security Exchange Name
SecurityExchangeName
NYSEAMER
CY2020 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0138393
CY2020 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26519954
CY2020 dei Entity Address City Or Town
EntityAddressCityOrTown
Winnemucca
CY2020 dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
CY2020 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89445
CY2020 dei City Area Code
CityAreaCode
775
CY2020 dei Local Phone Number
LocalPhoneNumber
625-3600
CY2020 dei Document Annual Report
DocumentAnnualReport
true
CY2020 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
33937080
CY2019Q4 dei Entity Public Float
EntityPublicFloat
15498938
CY2019Q2 us-gaap Assets Current
AssetsCurrent
812461
CY2019Q2 us-gaap Mineral Properties Net
MineralPropertiesNet
47055132
CY2019Q2 pzg Reclamation Bond Noncurrent
ReclamationBondNoncurrent
1401833
CY2019Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
48463268
CY2019Q2 us-gaap Assets
Assets
49275729
CY2019Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
980310
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26519954
CY2019 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
960870
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5970048
CY2020 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
976144
CY2020 pzg Stock Issued During Period Value Payment Of Interest Accrued
StockIssuedDuringPeriodValuePaymentOfInterestAccrued
119309
CY2020 pzg Stock Issued During Period Value Private Placement
StockIssuedDuringPeriodValuePrivatePlacement
4882966
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6430141
CY2020 us-gaap Profit Loss
ProfitLoss
-6430141
CY2019 us-gaap Profit Loss
ProfitLoss
-5970048
CY2020 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
976144
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
203192
CY2020 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
54421
CY2020 pzg Interest Expense Income
InterestExpenseIncome
324160
CY2019 pzg Proceeds From Sale Of Royalty On Mineral Property
ProceedsFromSaleOfRoyaltyOnMineralProperty
1927660
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4719
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
231527
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-259901
CY2019 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
52348
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5145291
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5633515
CY2020 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
4719
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1927660
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4882966
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2911286
CY2020 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
5201807
CY2020 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
35628
CY2019 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
960870
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10120401
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3872156
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4970391
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
166301
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
463690
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
297389
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5434081
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of these consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Significant estimates made by management in the accompanying consolidated financial statements include the adequacy of the Company&#8217;s reclamation and environmental obligation, share based compensation, warrant valuation, valuation of deferred tax asset, and assessment of impairment of mineral properties.</p>
CY2020 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to a concentration of credit risk consist principally of cash and cash equivalents.&nbsp;&nbsp;The Company maintains cash in accounts which may, at times, exceed federally insured limits.&nbsp;&nbsp;At June 30, 2020, the Company had $5.13 million of balances in excess of federally insured limits.&nbsp;&nbsp;The Company deposits its cash with financial institutions which it believes have sufficient credit quality to minimize the risk of loss.</p>
CY2019 us-gaap Nonmonetary Transaction Amount Of Barter Transaction
NonmonetaryTransactionAmountOfBarterTransaction
0
CY2020 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
1096791
CY2020Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.89
CY2019 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
2400000
CY2019Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
1.25
CY2019 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
3000000
CY2019 pzg Sale Of Equity Units Description Of Transaction
SaleOfEquityUnitsDescriptionOfTransaction
Each unit consists of one share of common stock and one warrant to purchase one-half of a share of common stock.
CY2020 us-gaap Asset Retirement Obligation Liabilities Settled
AssetRetirementObligationLiabilitiesSettled
723279
CY2020Q2 pzg Concentration Of Credit Risk Uninsured Cash Amount
ConcentrationOfCreditRiskUninsuredCashAmount
5130000
CY2020 pzg Cash Uninsured Amount Description
CashUninsuredAmountDescription
The Company deposits its cash with financial institutions which it believes have sufficient credit quality to minimize the risk of loss
CY2020 us-gaap Nonmonetary Transaction Amount Of Barter Transaction
NonmonetaryTransactionAmountOfBarterTransaction
0
CY2019 pzg Class Of Warrant Or Right Description
ClassOfWarrantOrRightDescription
Each warrant will have a two year term and will be exercisable at the following exercise prices: in the first year at $1.30 per share and in the second year at $1.50 per share. Also during the year ended June 30, 2019, the Company issued 1,045,000 shares from the exercising of warrants for gross proceeds of $0.96 million.
CY2019 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
90000
CY2019 pzg Net Proceeds From Issuance Or Sale Of Equity
NetProceedsFromIssuanceOrSaleOfEquity
2910000
CY2019 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
1045000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
690000
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
66668
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
20000
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
943992
CY2019Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.79
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.38
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.74
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
0.74
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.51
CY2020Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
153802
CY2019Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
108003
CY2020 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y18D
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
202121
CY2020 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
278181
CY2019 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
122406
CY2020Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
615170
CY2020 us-gaap Insurance Recoveries
InsuranceRecoveries
723279
CY2019 us-gaap Insurance Recoveries
InsuranceRecoveries
394785
CY2020 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
5631
CY2019 pzg Reimbursement Of Workers Compensation Insurance
ReimbursementOfWorkersCompensationInsurance
83
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1350330
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1253710
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
2426
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
2190
CY2020 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
-57853
CY2019 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
7671
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1405757
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1243849
CY2020 us-gaap Income Tax Examination Year Under Examination
IncomeTaxExaminationYearUnderExamination
2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
CY2020Q2 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
10575
CY2020 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
46885

Files In Submission

Name View Source Status
0001564590-20-044687-index-headers.html Edgar Link pending
0001564590-20-044687-index.html Edgar Link pending
0001564590-20-044687.txt Edgar Link pending
0001564590-20-044687-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gaejyeg013tc000001.jpg Edgar Link pending
gaejyeg013tc000002.jpg Edgar Link pending
gaejyeg013tc000003.jpg Edgar Link pending
gaejyeg013tc000004.jpg Edgar Link pending
gaejyeg013tc000005.jpg Edgar Link pending
gaejyeg013tc000006.jpg Edgar Link pending
gaejyeg013tc000007.jpg Edgar Link pending
guarb542e3ie000001.jpg Edgar Link pending
guarb542e3ie000002.jpg Edgar Link pending
pzg-10k_20200630.htm Edgar Link pending
pzg-20200630.xml Edgar Link completed
pzg-20200630.xsd Edgar Link pending
pzg-20200630_cal.xml Edgar Link unprocessable
pzg-20200630_def.xml Edgar Link unprocessable
pzg-20200630_lab.xml Edgar Link unprocessable
pzg-20200630_pre.xml Edgar Link unprocessable
pzg-ex211_7.htm Edgar Link pending
pzg-ex231_9.htm Edgar Link pending
pzg-ex311_11.htm Edgar Link pending
pzg-ex312_6.htm Edgar Link pending
pzg-ex321_8.htm Edgar Link pending
pzg-ex322_10.htm Edgar Link pending
pzg-ex41_325.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending